BioMed Central and Kennel Club launch new journal – Canine Genetics and Epidemiology - April 21, 2014
Open access publisher BioMed Central and the Kennel Club have announced the launch of the journal Canine Genetics and Epidemiology. The journal addresses genetic, genomic and epidemiological research in both domestic and wild canids, relating to breed and species diversity, and canine evolution. It will… Read More
Taylor & Francis launches updated mobile platform - April 21, 2014
Publisher Taylor & Francis has launched an updated version of its mobile platform, offering an enhanced reading experience, improved navigation and search, social sharing, in-app purchasing, and easier institutional access for all those who visit Taylor & Francis Online using their tablets or smartphones. Users… Read More
OCLC and Ingram help libraries manage e-book collections more efficiently - April 21, 2014
OCLC, the non-profit computer library service and research organisation, is working with Ingram to set and maintain holdings for e-books in WorldCat automatically, saving library staff valuable time and effort. This new program enables libraries with an OCLC cataloging subscription and an account with MyiLibrary®,… Read More
Latest edition of Blogspeak now online - April 21, 2014
The latest edition of Blogspeak is now online. Featured are: Martin Poulter (Creating an efficient workflow for publishing scholarly papers on Wikipedia); Kent Anderson (Public Access to Public Books: The Case of the National Trust); Kevin L. Smith (Of Bundles, Bindings, and the Next Great Copyright Law | Peer to… Read More
Elsevier announces availability of Reaxys tool’s new version - April 17, 2014
STM publisher Elsevier, Netherlands, has announced the availability of a new version of Reaxys, which offers a refined user interface with new search functionality that facilitates queries and expedites research. Using Reaxys, chemists can more easily find relevant and reliable answers without having to learn how… Read More
Thomson Reuters names 2014 Drugs to Watch - April 17, 2014
The Intellectual Property & Science business of Thomson Reuters has released its annual forecast of the drugs to watch in 2014, including three potential blockbuster treatments anticipated to attain more than $1 billion in sales through 2019, after entering the marketplace this year. The study… Read More
